CXCL13 and synovial sarcoma: Recent studies have shown that elevated serum levels rather than saliva levels of CXCL13 in SS patients are correlated with the histomorphometric features of the salivary glands, including the size of aggregates and the formation of GCs (52, 53), as well as with the risk and incidence of NHL (54, 55).